Avantor, Inc. (AVTR): Cash & Equivalents
$365.40M
As of 2025-12-31
$279.30M
As of 2026-03-31
-0.7%
3-year compound annual growth
+5.0%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $365.40M | +39.5% | 2026-02-11, Balance as of period end |
| 2024-12-31 | $261.90M | -0.4% | 2026-02-11, Balance as of period end |
| 2023-12-31 | $262.90M | -29.5% | 2025-02-07, Balance as of period end |
| 2022-12-31 | $372.90M | +23.6% | 2024-02-14, Balance as of period end |
| 2021-12-31 | $301.70M | +5.3% | 2023-02-14, Balance as of period end |
| 2020-12-31 | $286.60M | +53.5% | 2022-02-11, Balance as of period end |
| 2019-12-31 | $186.70M | +1.1% | 2021-02-16, Balance as of period end |
| 2018-12-31 | $184.70M | n/a | 2020-02-14, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Avantor, Inc. (AVTR) | 2025-12-31 | $365.40M | +39.5% |
| Agilent Technologies, Inc. (A) | 2025-10-31 | $1.79B | +34.6% |
| Bruker Corp (BRKR) | 2025-12-31 | $298.80M | +62.9% |
| Waters Corp (WAT) | 2025-12-31 | $587.83M | +80.7% |
| Revvity, Inc. (RVTY) | 2025-12-28 | $919.86M | -20.9% |
| Bio-Rad Laboratories, Inc. (BIO) | 2025-12-31 | $529.80M | +8.5% |
| 10x Genomics, Inc. (TXG) | 2024-12-31 | $344.07M | -4.2% |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | $90.85M | -8.0% |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | $63.71M | +15.1% |
Compare AVTR, A, BRKR, WAT side by side · Screen every company in Laboratory Analytical Instruments ↗